$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
RNA-seq has been widely used over the years typically for estimating differential gene expression and gene discovery1. In addition, it can also be utilized to estimate varying exon level usage due to gene expressing different isoforms, hence contributing to a better understanding of gene regulation at the post-transcriptional level. The majority of eukaryotic genes generate different isoforms by alternative splicing (AS) to increase the diversity of mRNA expression. AS events can be divided into different patterns: skipping of complete exons (SE) where a ("cassette") exon is completely removed out of the transcript along with its flanking introns; alternative (donor) 5' splice site selection (A5SS) and alternative 3' (acceptor) splice site selection (A3SS) when two or more splice sites are present on either end of an exon; retention of introns (RI) when an intron is retained within the mature mRNA transcript and mutual exclusion of exon usage (MXE) where only one of the two available exons can be retained at a time2,3. Alternative polyadenylation (APA) also plays an important role in regulating gene expression using alternative poly (A) sites to generate multiple mRNA isoforms from a single transcript4. Most polyadenylation sites (pAs) are located in the 3' untranslated region (3' UTRs), generating mRNA isoforms with diverse 3' UTR lengths. As the 3' UTR is the central hub for recognizing regulatory elements, different 3' UTR lengths can affect mRNA localization, stability and translation5. There are a class of 3' end sequencing assays optimized to detect APA that differ in the details of the protocol6. The pipeline described here is designed for PolyA-seq, but can be adapted for other protocols as described.
In this study, we present a pipeline of differential exon analysis methods7,8 (Figure 1), which can be divided into two broad categories: exon-based (DEXSeq9, diffSplice10) and event-based (replicate Multivariate Analysis of Transcript Splicing (rMATS)11). The exon-based methods compare the fold change across conditions of individual exons, against a measure of overall gene fold change to call differentially expressed exon usage, and from that compute a gene-level measure of AS activity. Event-based methods use exon-intron-spanning junction reads to detect and classify specific splicing events such as exon skipping or retention of introns, and distinguish these AS types in the output3. Thus, these methods provide complementary views for a complete analysis of AS12,13. We selected DEXSeq (based on the DESeq214 DGE package) and diffSplice (based on the Limma10 DGE package) for the study as they are amongst the most widely used packages for differential splicing analysis. rMATS was chosen as a popular method for event-based analysis. Another popular event-based method is MISO (Mixture of Isoforms)1. For APA we adapt the exon-based approach.

Figure 1. Analysis pipeline. Flowchart of the steps used in the analysis. Steps include: obtaining the data, performing quality checks and read alignment followed by counting reads using annotations for known exons, introns and pA sites, filtering to remove low counts and normalization. PolyA-seq data was analysed for alternative pA sites using diffSplice/DEXSeq methods, bulk RNA-Seq was analysed for alternative splicing at the exon level with diffSplice/DEXseq methods, and AS events analysed with rMATS. Please click here to view a larger version of this figure.
The RNA-seq data used in this survey was acquired from Gene Expression Omnibus (GEO) (GSE138691)15. We used mouse RNA-seq data from this study with two condition groups: wild-type (WT) and Muscleblind-like type 1 knockout (Mbnl1 KO) with three replicates each. To demonstrate differential polyadenylation site usage analysis, we obtained mouse embryo fibroblasts (MEFs) PolyA-seq data (GEO Accession GSE60487)16. The data has four condition groups: Wild-type (WT), Muscleblind-like type1/type 2 double knockout (Mbnl1/2 DKO), Mbnl 1/2 DKO with Mbnl3 knockdown (KD) and Mbnl1/2 DKO with Mbnl3 control (Ctrl). Each condition group consists of two replicates.
| GEO Accession | SRA Run number | Sample name | Condition | Replicate | Tissue | Sequencing | Read length |
| RNA-Seq | GSM4116218 | SRR10261601 | Mbnl1KO_Thymus_1 | Mbnl1 knockout | Rep 1 | Thymus | Paired-end | 100 bp |
| GSM4116219 | SRR10261602 | Mbnl1KO_Thymus_2 | Mbnl1 knockout | Rep 2 | Thymus | Paired-end | 100 bp |
| GSM4116220 | SRR10261603 | Mbnl1KO_Thymus_3 | Mbnl1 knockout | Rep 3 | Thymus | Paired-end | 100 bp |
| GSM4116221 | SRR10261604 | WT_Thymus_1 | Wild type | Rep 1 | Thymus | Paired-end | 100 bp |
| GSM4116222 | SRR10261605 | WT_Thymus_2 | Wild type | Rep 2 | Thymus | Paired-end | 100 bp |
| GSM4116223 | SRR10261606 | WT_Thymus_3 | Wild type | Rep 3 | Thymus | Paired-end | 100 bp |
| 3P-Seq | GSM1480973 | SRR1553129 | WT_1 | Wild type (WT) | Rep 1 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 40 bp |
| GSM1480974 | SRR1553130 | WT_2 | Wild type (WT) | Rep 2 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 40 bp |
| GSM1480975 | SRR1553131 | DKO_1 | Mbnl 1/2 double knockout (DKO) | Rep 1 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 40 bp |
| GSM1480976 | SRR1553132 | DKO_2 | Mbnl 1/2 double knockout (DKO) | Rep 2 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 40 bp |
| GSM1480977 | SRR1553133 | DKOsiRNA_1 | Mbnl 1/2 double knockout with Mbnl 3 siRNA (KD) | Rep 1 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 40 bp |
| GSM1480978 | SRR1553134 | DKOsiRNA_2 | Mbnl 1/2 double knockout with Mbnl 3 siRNA (KD) | Rep 2 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 36 bp |
| GSM1480979 | SRR1553135 | DKONTsiRNA_1 | Mbnl 1/2 double knockout with non-targeting siRNA (Ctrl) | Rep 1 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 40 bp |
| GSM1480980 | SRR1553136 | DKONTsiRNA_2 | Mbnl 1/2 double knockout with non-targeting siRNA (Ctrl) | Rep 2 | Mouse embryonic Fibroblasts (MEFs) | Single-end | 40 bp |
Table 1. Summary of RNA-Seq and PolyA-seq datasets used for the analysis.